Organogenesis Holdings Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.02 | -$0.02 | -$0.02 |
Q2 2024 | 1 | $0.00 | $0.01 | $0.01 |
Q3 2024 | 1 | -$0.02 | -$0.02 | -$0.02 |
Q4 2024 | 1 | -$0.01 | -$0.01 | -$0.01 |
Q1 2025 | 1 | $0.02 | $0.02 | $0.02 |
Q2 2025 | 1 | $0.05 | $0.05 | $0.05 |
Q3 2025 | 1 | $0.04 | $0.04 | $0.04 |
Q4 2025 | 1 | $0.04 | $0.04 | $0.04 |
Organogenesis Holdings Inc. Earnings Date And Information
Organogenesis Holdings Inc. last posted its earnings results on Thursday, August 8th, 2024. The company reported $-0.13 earnings per share for the quarter, missing analysts' consensus estimates of $-0.02 by $0.11. The company had revenue of 115.18 M for the quarter and had revenue of 433.14 M for the year. Organogenesis Holdings Inc. has generated $0 earnings per share over the last year ($0.0373 diluted earnings per share) and currently has a price-to-earnings ratio of -70.78. Organogenesis Holdings Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
Organogenesis Holdings Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/12/2024 | Q3 2024 | $0.09 | $108.83 M | $115.18 M | ||
08/08/2024 | Q2 2024 | -$0.02 | -$0.13 | -0.11 | $121.30 M | $130.23 M |
05/09/2024 | Q1 2024 | -$0.02 | -$0.02 | 0 | $109.98 M | |
02/29/2024 | Q4 2023 | -$0.00 | -$0.00 | -0 | $99.65 M | |
11/09/2023 | Q3 2023 | $0.01 | $0.09 | 0.09 | $111.43 M | $108.53 M |
08/09/2023 | Q2 2023 | $0.03 | $0.04 | 0.02 | $115.09 M | $117.32 M |
05/10/2023 | Q1 2023 | -$0.02 | -$0.02 | -0 | $107.64 M | |
03/01/2023 | Q4 2022 | $0.05 | $0.06 | 0.01 | $115.52 M | |
11/09/2022 | Q3 2022 | $0.06 | $0.00 | -0.06 | $120.85 M | $116.86 M |
08/09/2022 | Q2 2022 | $0.08 | $0.07 | -0.01 | $120.91 M | $121.40 M |
05/10/2022 | Q1 2022 | $0.05 | $0.00 | -0.05 | $98.12 M | |
03/01/2022 | Q4 2021 | $0.08 | $0.40 | 0.32 | $128.56 M | |
11/09/2021 | Q3 2021 | $0.06 | $0.10 | 0.04 | $112.24 M | $113.75 M |
08/09/2021 | Q2 2021 | $0.07 | $0.16 | 0.09 | $105.95 M | $123.20 M |
05/10/2021 | Q1 2021 | $0.08 | $102.55 M | |||
03/16/2021 | Q4 2020 | $0.14 | $0.16 | 0.02 | $106.81 M | |
11/09/2020 | Q3 2020 | -$0.08 | $0.20 | 0.28 | $71.95 M | $100.80 M |
08/10/2020 | Q2 2020 | -$0.12 | -$0.05 | 0.07 | $58.82 M | $68.96 M |
05/11/2020 | Q1 2020 | -$0.12 | -$0.16 | -0.04 | $61.73 M | |
03/09/2020 | Q4 2019 | -$0.10 | -$0.05 | 0.06 | $74.65 M |
Organogenesis Holdings Inc. Earnings: Frequently Asked Questions
-
When is Organogenesis Holdings Inc.'s earnings date?
Organogenesis Holdings Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
How can I listen to Organogenesis Holdings Inc.'s earnings conference call?
The conference call for Organogenesis Holdings Inc.'s latest earnings report can be listened to online.
-
How can I read Organogenesis Holdings Inc.'s conference call transcript?
The conference call transcript for Organogenesis Holdings Inc.'s latest earnings report can be read online.
-
How much revenue does Organogenesis Holdings Inc. generate each year?
Organogenesis Holdings Inc. (:ORGO) has a recorded annual revenue of $433.14 M.
-
How much profit does Organogenesis Holdings Inc. generate each year?
Organogenesis Holdings Inc. (:ORGO) has a recorded net income of $433.14 M. Organogenesis Holdings Inc. has generated $0.0377 earnings per share over the last four quarters.
-
What is Organogenesis Holdings Inc.'s price-to-earnings ratio?
Organogenesis Holdings Inc. (:ORGO) has a price-to-earnings ratio of -70.78 and price/earnings-to-growth ratio is -51.31.